InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: None

Wednesday, 08/09/2017 3:27:44 PM

Wednesday, August 09, 2017 3:27:44 PM

Post# of 8484
Lilly Phase 1 trial with HALO

A Study to Assess the Amount of LY3074828 That Gets Into the Body When Given With LY9999QS, in Healthy Participants


This study is currently recruiting participants.
See Contacts and Locations

Verified July 2017 by Eli Lilly and Company

Sponsor:

Eli Lilly and Company

Collaborator:

Halozyme Therapeutics

Information provided by (Responsible Party):

Eli Lilly and Company


ClinicalTrials.gov Identifier:

NCT03220126

First received: July 14, 2017

Last updated: July 21, 2017

Last verified: July 2017

History of Changes


Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News